专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

KR100646938B1 헬리코박터 필로리의 정착과 생육 활성을 저해하는락토바실루스 람노서스 아이디씨씨 3201 有权
标题翻译： 헬리코박터필로리의정착과생육활을락토락토씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨씨3201
公开(公告)号：KR100646938B1
公开(公告)日：2006-11-23
申请号：KR1020050088895
申请日：2005-09-23
申请人： 일동홀딩스(주)
发明人： 김태용 , 강병화 , 권혁상 , 양은희
IPC分类号： C12N1/20
摘要： A microorganism Lactobacillus rhamnosus IDCC 3201 is provided to inhibit adhesion to stomach mucosa of Helicobacter pylori by competitively adhering to the stomach mucosa with Helicobacter pylori, and inhibit growth of Helicobacter pylori by producing antibiotic substances including lactic acid, bacteriocin and hydrogen peroxide. The microorganism Lactobacillus rhamnosus IDCC 3201(KCTC-10833BP) for inhibiting the adhesion to stomach mucosa and growth of Helicobacter pylori is provided, wherein Lactobacillus rhamnosus IDCC 3201(KCTC-10833BP) is isolated from Korean infant's feces, and digestion organs of cow, pig and dog. A composition or food for inhibiting activity of Helicobacter pylori comprises Lactobacillus rhamnosus IDCC 3201(KCTC-10833BP) as effective ingredient, wherein the food is fermented milk, yoghurt, drink, milk drink, food additive or health food.
摘要翻译：提供了一种微生物鼠李糖乳杆菌IDCC 3201，通过与幽门螺杆菌竞争性地粘附于胃粘膜来抑制与幽门螺杆菌的胃粘膜的粘附，并且通过产生包括乳酸，细菌素和过氧化氢的抗生素物质来抑制幽门螺杆菌的生长。提供了用于抑制与胃粘膜的粘附和幽门螺杆菌生长的微生物鼠李糖乳杆菌IDCC 3201（KCTC-10833BP），其中从韩国婴儿的粪便中分离鼠李糖乳杆菌IDCC 3201（KCTC-10833BP），并且母牛，猪的消化器官和狗。用于抑制幽门螺杆菌活性的组合物或食品包含鼠李糖乳杆菌IDCC 3201（KCTC-10833BP）作为有效成分，其中食品为发酵乳，酸奶，饮料，乳饮料，食品添加剂或保健食品。

12. 发明公开

KR1020050012505A 비피도박테리움 속 균종의 동정방법 有权
标题翻译：鉴定双歧杆菌SP的方法具有减少时间的应变和改进的精度
公开(公告)号：KR1020050012505A
公开(公告)日：2005-02-02
申请号：KR1020030051487
申请日：2003-07-25
申请人： 일동홀딩스(주)
发明人： 김태용 , 강병화 , 권혁상 , 양은희 , 이승훈
IPC分类号： C12Q1/68
摘要： PURPOSE: A method for identification of a Bifidobacterium sp. strain is provided, thereby rapidly and accurately identifying the Bifidobacterium sp. strain using Bifidobacterium sp. specific and common primers. CONSTITUTION: A Bifidobacterium sp. specific primer has the nucleotide sequence selected from SEQ ID NO:1 to SEQ ID NO:8. A Bifidobacterium sp. common primer has the nucleotide sequence selected from SEQ ID NO:9 and SEQ ID NO:10. The method for identification of a Bifidobacterium sp. strain comprises the steps of: (1) PCR amplifying a test chromosomal DNA as a template using one Bifidobacterium sp. specific primer selected from SEQ ID NO:1 to SEQ ID NO:8 and one Bifidobacterium sp. common primer selected from SEQ ID NO:9 to SEQ ID NO:10; and (2) determining whether the PCR product is amplified and the size of the PCR product, wherein the Bifidobacterium sp is one or more selected from B. adolescentis, B. animalis, B. bifidum, B. breve, B. infantis, B. lactis, B. longum and B. pseudolongum.
摘要翻译：目的：鉴定双歧杆菌属的方法。提供菌株，从而快速准确地鉴定双歧杆菌。应用双歧杆菌特异性和常用引物。构成：双歧杆菌特异性引物具有选自SEQ ID NO：1至SEQ ID NO：8的核苷酸序列。双歧杆菌普通引物具有选自SEQ ID NO：9和SEQ ID NO：10的核苷酸序列。鉴定双歧杆菌属的方法菌株包括以下步骤：（1）使用一种双歧杆菌菌株PCR扩增测试染色体DNA作为模板。选自SEQ ID NO：1至SEQ ID NO：8的特异性引物和一种双歧杆菌属选自SEQ ID NO：9至SEQ ID NO：10的共同引物; 和（2）确定PCR产物是否被扩增，以及PCR产物的大小，其中双歧杆菌属是选自青春双歧杆菌，动物链球菌，双歧杆菌，短双歧杆菌，婴儿双歧杆菌，B 乳酸菌，长双歧杆菌和假单胞菌。

13. 发明公开

KR1020110056686A 호모이소플라바논을 유효성분으로 함유하는 비만 또는 대사증후군 예방 및 치료용 조성물 有权
标题翻译：用于预防或治疗肥胖或代谢综合征的组合物
公开(公告)号：KR1020110056686A
公开(公告)日：2011-05-31
申请号：KR1020090113119
申请日：2009-11-23
申请人： 일동홀딩스(주)
发明人： 권혁상 , 고종희 , 유종수 , 윤종민 , 장현수 , 유정수 , 연승우 , 강재훈
IPC分类号： A61K31/37 , A61P3/04 , A23L1/30 , A61K36/8969
CPC分类号： A61K36/8969 , A23L33/105 , A23V2002/00 , A61K31/37 , A23V2200/332 , A23V2250/2116
摘要： PURPOSE: A composition containing homoisoflavanone for preventing and treating obesity or metabolic syndrome is provided to suppress adipoctye differentiation and to reduce body fat, abdominal fat, and glucose tolerance. CONSTITUTION: A composition for preventing and treating obesity or metabolic syndrome contains homoisoflavanone and pharmaceutically acceptable salt thereof as an active ingredient. The homoisolfavanone and pharmaceutically acceptable salt thereof are denoted by chemical formulas 1 and 2. The homoisoflavanone is isolated from Polygonatum odoratum var. pluriflorum by a solvent or chromatography.
摘要翻译：目的：提供一种含有异丙叉酮用于预防和治疗肥胖症或代谢综合征的组合物，以抑制脂肪分化，减少体脂肪，腹部脂肪和葡萄糖耐量。构成：用于预防和治疗肥胖症或代谢综合征的组合物含有高异黄酮及其可药用盐作为活性成分。异高粱醇酮及其药学上可接受的盐由化学式1和化学式2表示。异黄烷酮是从金缕梅（Polygonatum odoratum var。通过溶剂或色谱法分离。

14. 发明公开

KR1020100107671A 혈전용해능이 있는 단백분해효소를 고생산하는 바실루스 서브틸리스 아이디씨씨 9204 有权
标题翻译： BACILLUS SUBTILIS IDCC 9204，具有纤维素活性的抗菌酶的高产量
公开(公告)号：KR1020100107671A
公开(公告)日：2010-10-06
申请号：KR1020090025883
申请日：2009-03-26
申请人： 일동홀딩스(주)
发明人： 강병화 , 권혁상 , 이승훈 , 김성범 , 강재훈
IPC分类号： C12N1/20 , A23L2/84 , C12R1/125
摘要： PURPOSE: A Bacillus subtilis IDCC 2904 which produces thrombolysis enzyme is provided to improve blood circulation and use in various health foods. CONSTITUTION: A Bacillus subtilis IDCC 9204(deposit number: KCTC 11471 BP) highly produces protease with thrombolytic ability. A health food contains 27.7kDa protease as an active ingredient which is obtained by culturing Bacillus subtilis IDCC 9204. The Bacillus subtilis IDCC 9204 is isolated from soybean paste, fermented soybean paste, and Natto.
摘要翻译：目的：提供产生溶栓酶的枯草芽孢杆菌IDCC 2904，以改善血液循环和在各种保健食品中的使用。构成：枯草芽孢杆菌IDCC 9204（保藏号：KCTC 11471 BP）高度产生具有溶栓能力的蛋白酶。保健食品含有通过培养枯草芽孢杆菌IDCC 9204获得的27.7kDa蛋白酶作为活性成分。从大豆酱，发酵大豆酱和纳豆中分离出枯草芽孢杆菌IDCC 9204。

15. 发明授权

KR100736517B1 장내 유해세균 억제능을 갖는 락토바실루스 존소니이 아이디씨씨 9203 有权
标题翻译： 장내유해세균억제능을갖는락토바실루스존소니이아이디씨씨9203
公开(公告)号：KR100736517B1
公开(公告)日：2007-07-06
申请号：KR1020060047726
申请日：2006-05-26
申请人： 일동홀딩스(주)
发明人： 김태용 , 강병화 , 권혁상 , 양은희 , 이승훈
IPC分类号： C12N1/20
摘要： A microorganism having antibacterial activity, Lactobacillus johnsonii IDCC 9203, is provided to normalize intestinal flora by inhibiting growth of intestinal harmful bacteria including anaerobic bacteria and food poisoning-causing bacteria in the intestine. The microorganism capable of inhibiting growth of intestinal harmful bacteria, Lactobacillus johnsonii IDCC 9203(KCTC 10923BP), is isolated from the infant feces. The probiotic product or food contains Lactobacillus johnsonii IDCC 9203(KCTC 10923BP) as an effective ingredient, wherein the food is fermented milk, yoghurt, drink, food additive or health food.
摘要翻译：提供具有抗菌活性的微生物约氏乳杆菌IDCC9203，以通过抑制肠道有害菌的生长来使肠道菌群正常化，所述肠道有害菌包括厌氧细菌和肠内引起食物中毒的细菌。从婴儿粪便中分离出能够抑制肠道有害菌生长的微生物，约氏乳杆菌IDCC 9203（KCTC 10923BP）。益生菌产品或食品含有约氏乳杆菌IDCC 9203（KCTC 10923BP）作为有效成分，其中食品为发酵乳，酸奶，饮料，食品添加剂或保健食品。

16. 发明授权

KR100443080B1 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주 有权
标题翻译： 콜레스테롤저하능을갖을갖는스트렙토코커스페시움균주
公开(公告)号：KR100443080B1
公开(公告)日：2004-08-04
申请号：KR1020020040450
申请日：2002-07-11
申请人： 일동홀딩스(주)
发明人： 김기원 , 김태용 , 강병화 , 권혁상 , 유정수 , 양은희
IPC分类号： C12N1/20
摘要： PURPOSE: A microorganism Streptococcus faecium having cholesterol-reducing activity is provided, thereby inhibiting absorption of cholesterol into small intestine. CONSTITUTION: A microorganism Streptococcus faecium ID9201 (KCCM-10313) having cholesterol-reducing activity is provided, wherein Streptococcus faecium ID9201 (KCCM-10313) is isolated from Korean fetal feces; Streptococcus faecium ID9201 (KCCM-10313) is administered orally to a human being in the amount of 1x10(8) to 40x10(8) cfu/kg, preferably 10x10(8) to 20x10(8) cfu/kg per a day. An agent for reducing cholesterol in blood comprises Streptococcus faecium ID9201 (KCCM-10313) as an active ingredient.
摘要翻译：目的：提供具有降胆固醇活性的微生物链球菌屎肠球菌，从而抑制胆固醇吸收进入小肠。组成：提供了具有降胆固醇活性的微生物屎链球菌ID9201（KCCM-10313），其中从韩国胎儿粪便中分离屎链球菌ID9201（KCCM-10313）屎链球菌ID9201（KCCM-10313）以每天1×10 8至40×10 8 cfu / kg，优选10×10 8至20×10 8 cfu / kg的量口服施用于人。用于降低血液中胆固醇的药物包含屎链球菌ID9201（KCCM-10313）作为活性成分。

17. 发明公开

KR1020040007855A 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주 有权
标题翻译：具有减少胆固醇活性的MICROORGANISM STREPTOCOCCUS FAECIUM
公开(公告)号：KR1020040007855A
公开(公告)日：2004-01-28
申请号：KR1020020040450
申请日：2002-07-11
申请人： 일동홀딩스(주)
发明人： 김기원 , 김태용 , 강병화 , 권혁상 , 유정수 , 양은희
IPC分类号： C12N1/20
摘要： PURPOSE: A microorganism Streptococcus faecium having cholesterol-reducing activity is provided, thereby inhibiting absorption of cholesterol into small intestine. CONSTITUTION: A microorganism Streptococcus faecium ID9201 (KCCM-10313) having cholesterol-reducing activity is provided, wherein Streptococcus faecium ID9201 (KCCM-10313) is isolated from Korean fetal feces; Streptococcus faecium ID9201 (KCCM-10313) is administered orally to a human being in the amount of 1x10(8) to 40x10(8) cfu/kg, preferably 10x10(8) to 20x10(8) cfu/kg per a day. An agent for reducing cholesterol in blood comprises Streptococcus faecium ID9201 (KCCM-10313) as an active ingredient.
摘要翻译：目的：提供具有降胆固醇活性的微生物屎链球菌，从而抑制胆固醇向小肠吸收。构成：提供具有降胆固醇活性的微生物屎肠球菌ID9201（KCCM-10313），其中从韩国胎粪中分离屎肠球菌ID9201（KCCM-10313）蓖麻蛔虫ID9201（KCCM-10313）以每天1×10 8至40×10 8（8）cfu / kg，优选10×10（8）至20×10（8）cfu / kg的量口服施用。用于降低血液中胆固醇的试剂包括蓖麻链球菌ID9201（KCCM-10313）作为活性成分。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式